Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-04-25 Sale | 2019-04-25 6:49 pm | ALDER BIOPHARMACEUTICALS INC | ALDR | Lavelle Erin Chief Operating Officer | 1,434 | $13.67 | $19,599 | 4,408 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-08 Option Award | 2023-06-09 4:25 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-10-31 Option Award | 2022-11-02 7:08 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 170,000 | $0 | 170,000 (Direct) | View |
2022-05-12 Option Award | 2022-05-16 6:23 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-01-27 Option Award | 2022-01-31 5:16 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 170,000 | $0 | 170,000 (Direct) | View |
Ownership | 2021-08-09 6:11 pm | N/A 2031-02-25 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 0 | $0 | 357,138 (Direct) | View |
2019-10-22 Option Award | 2019-10-24 7:12 pm | N/A N/A | ALDER BIOPHARMACEUTICALS INC | ALDR | Lavelle Erin Chief Operating Officer | 11,684 | $0 | 0 (Direct) | View |
2019-10-22 Equity Swap | 2019-10-24 7:12 pm | N/A N/A | ALDER BIOPHARMACEUTICALS INC | ALDR | Lavelle Erin Chief Operating Officer | 16,092 | $18 | 0 (Direct) | View |
2019-10-22 Disposition | 2019-10-24 7:12 pm | N/A 2028-04-15 | ALDER BIOPHARMACEUTICALS INC | ALDR | Lavelle Erin Chief Operating Officer | 450,000 | $0 | 0 (Direct) | View |
2019-04-23 Option Award | 2019-04-25 6:49 pm | N/A N/A | ALDER BIOPHARMACEUTICALS INC | ALDR | Lavelle Erin Chief Operating Officer | 5,842 | $0 | 4,408 (Direct) | View |